Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Bamlanivimab Plus Etesevimab in Mild or Moderate COVID-19
- Compliance With Statins and Associations With Cardiovascular Risk and Death in Low-Risk Individuals With Type 2 Diabetes
- Safety and Efficacy of NVX-CoV2373 COVID-19 Vaccine
- SLGT2 Inhibitors vs Sulfonylureas in Type 2 Diabetes
- SARS-CoV-2 Variants and Vaccines
- Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin
- Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes
- Association Between Egg Consumption and Risk of CV Outcomes
- Implications of eGFR Dip Following SGLT2 Inhibitor Initiation on Cardiovascular and Kidney Outcomes
- Long-Term Follow-Up of Heart Outcomes Evaluation Prevention (HOPE-3) Participants